New Zealand markets closed

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
62.12-0.09 (-0.14%)
At close: 04:00PM EDT
62.12 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.76B
Enterprise value 10.18B
Trailing P/E 44.69
Forward P/E 31.35
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.76
Price/book (mrq)4.97
Enterprise value/revenue 8.90
Enterprise value/EBITDA 27.09

Trading information

Stock price history

Beta (5Y monthly) 1.22
52-week change 3-26.14%
S&P500 52-week change 320.07%
52-week high 389.91
52-week low 351.79
50-day moving average 370.37
200-day moving average 371.65

Share statistics

Avg vol (3-month) 31.07M
Avg vol (10-day) 31.02M
Shares outstanding 5157.19M
Implied shares outstanding 6157.19M
Float 8155.39M
% held by insiders 10.97%
% held by institutions 1100.52%
Shares short (28 Mar 2024) 45.32M
Short ratio (28 Mar 2024) 44.62
Short % of float (28 Mar 2024) 44.40%
Short % of shares outstanding (28 Mar 2024) 43.39%
Shares short (prior month 29 Feb 2024) 44.58M

Dividends & splits

Forward annual dividend rate 40.32
Forward annual dividend yield 40.52%
Trailing annual dividend rate 30.32
Trailing annual dividend yield 30.51%
5-year average dividend yield 40.44
Payout ratio 423.02%
Dividend date 326 Feb 2024
Ex-dividend date 409 Feb 2024
Last split factor 24:1
Last split date 330 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.58%
Operating margin (ttm)18.39%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)11.83%

Income statement

Revenue (ttm)1.14B
Revenue per share (ttm)7.26
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)N/A
EBITDA 323.36M
Net income avi to common (ttm)224.11M
Diluted EPS (ttm)1.39
Quarterly earnings growth (yoy)-45.10%

Balance sheet

Total cash (mrq)135.65M
Total cash per share (mrq)0.86
Total debt (mrq)555.7M
Total debt/equity (mrq)28.30%
Current ratio (mrq)4.37
Book value per share (mrq)12.49

Cash flow statement

Operating cash flow (ttm)276.43M
Levered free cash flow (ttm)162.75M